141 related articles for article (PubMed ID: 24292754)
1. Slowly progressive type 1 diabetes treated with metformin for five years after onset.
Hirata T; Shimada A; Morimoto J; Maruyama T
Intern Med; 2013; 52(23):2635-7. PubMed ID: 24292754
[TBL] [Abstract][Full Text] [Related]
2. Slowly progressive insulin-dependent (type 1) diabetes positive for anti-GAD antibody ELISA test may be strongly associated with a future insulin-dependent state.
Oikawa Y; Tanaka H; Uchida J; Atsumi Y; Osawa M; Katsuki T; Kawai T; Shimada A
Endocr J; 2017 Feb; 64(2):163-170. PubMed ID: 27760891
[TBL] [Abstract][Full Text] [Related]
3. Insulin intervention in slowly progressive insulin-dependent (type 1) diabetes mellitus.
Maruyama T; Tanaka S; Shimada A; Funae O; Kasuga A; Kanatsuka A; Takei I; Yamada S; Harii N; Shimura H; Kobayashi T
J Clin Endocrinol Metab; 2008 Jun; 93(6):2115-21. PubMed ID: 18397986
[TBL] [Abstract][Full Text] [Related]
4. Clinical and Genetic Characteristics of Non-Insulin-Requiring Glutamic Acid Decarboxylase (GAD) Autoantibody-Positive Diabetes: A Nationwide Survey in Japan.
Yasui J; Kawasaki E; Tanaka S; Awata T; Ikegami H; Imagawa A; Uchigata Y; Osawa H; Kajio H; Kawabata Y; Shimada A; Takahashi K; Yasuda K; Yasuda H; Hanafusa T; Kobayashi T;
PLoS One; 2016; 11(5):e0155643. PubMed ID: 27177031
[TBL] [Abstract][Full Text] [Related]
5. Rapid Normalization of High Glutamic Acid Decarboxylase Autoantibody Titers and Preserved Endogenous Insulin Secretion in a Patient with Diabetes Mellitus: A Case Report and Literature Review.
Ohara N; Kaneko M; Furukawa T; Koike T; Sone H; Tanaka S; Kaneko K; Kamoi K
Intern Med; 2016; 55(5):485-9. PubMed ID: 26935368
[TBL] [Abstract][Full Text] [Related]
6. Glutamic Acid Decarboxylase Autoantibody-negative Slowly Progressive Type 1 Diabetes Mellitus: A Case Report and Literature Review.
Kobayashi M; Ohara N; Ikeda Y; Nagano O; Takada T; Kodama M; Sone H
Intern Med; 2018 Dec; 57(24):3581-3587. PubMed ID: 30101912
[TBL] [Abstract][Full Text] [Related]
7. Exponential increase of glutamic acid decarboxylase (GAD) antibody titer after initiating and stopping insulin in a patient with slowly progressive type 1 diabetes.
Nishimura A; Nagasawa K; Okubo M; Kobayashi T; Mori Y
Endocr J; 2015; 62(12):1077-82. PubMed ID: 26440526
[TBL] [Abstract][Full Text] [Related]
8. Unique epitopes of glutamic acid decarboxylase autoantibodies in slowly progressive type 1 diabetes.
Kobayashi T; Tanaka S; Okubo M; Nakanishi K; Murase T; Lernmark A
J Clin Endocrinol Metab; 2003 Oct; 88(10):4768-75. PubMed ID: 14557453
[TBL] [Abstract][Full Text] [Related]
9. Insulin intervention to preserve beta cells in slowly progressive insulin-dependent (type 1) diabetes mellitus.
Kobayashi T; Maruyama T; Shimada A; Kasuga A; Kanatsuka A; Takei I; Tanaka S; Yokoyama J
Ann N Y Acad Sci; 2002 Apr; 958():117-30. PubMed ID: 12021091
[TBL] [Abstract][Full Text] [Related]
10. Adult-onset autoimmune diabetes identified by glutamic acid decarboxylase autoantibodies: a retrospective cohort study.
Wada E; Onoue T; Kinoshita T; Hayase A; Handa T; Ito M; Furukawa M; Okuji T; Kobayashi T; Iwama S; Sugiyama M; Takagi H; Hagiwara D; Suga H; Banno R; Goto M; Arima H
Diabetologia; 2021 Oct; 64(10):2183-2192. PubMed ID: 34268631
[TBL] [Abstract][Full Text] [Related]
11. GAD treatment and insulin secretion in recent-onset type 1 diabetes.
Ludvigsson J; Faresjö M; Hjorth M; Axelsson S; Chéramy M; Pihl M; Vaarala O; Forsander G; Ivarsson S; Johansson C; Lindh A; Nilsson NO; Aman J; Ortqvist E; Zerhouni P; Casas R
N Engl J Med; 2008 Oct; 359(18):1909-20. PubMed ID: 18843118
[TBL] [Abstract][Full Text] [Related]
12. Pioglitazone may accelerate disease course of slowly progressive type 1 diabetes.
Shimada A; Shigihara T; Okubo Y; Katsuki T; Yamada Y; Oikawa Y
Diabetes Metab Res Rev; 2011 Nov; 27(8):951-3. PubMed ID: 22069291
[TBL] [Abstract][Full Text] [Related]
13. Diabetes autoantibodies do not predict progression to diabetes in adults: the Diabetes Prevention Program.
Dabelea D; Ma Y; Knowler WC; Marcovina S; Saudek CD; Arakaki R; White NH; Kahn SE; Orchard TJ; Goldberg R; Palmer J; Hamman RF;
Diabet Med; 2014 Sep; 31(9):1064-8. PubMed ID: 24646311
[TBL] [Abstract][Full Text] [Related]
14. [Slowly progressive IDDM (SPIDDM)].
Kobayashi T
Nihon Rinsho; 1997 Nov; 55 Suppl():604-7. PubMed ID: 9434535
[No Abstract] [Full Text] [Related]
15. Multicenter prevention trial of slowly progressive type 1 diabetes with small dose of insulin (the Tokyo study): preliminary report.
Maruyama T; Shimada A; Kanatsuka A; Kasuga A; Takei I; Yokoyama J; Kobayashi T
Ann N Y Acad Sci; 2003 Nov; 1005():362-9. PubMed ID: 14679093
[TBL] [Abstract][Full Text] [Related]
16. The over 50 year clinical course of a patient with slowly progressive type 1 diabetes (SPIDDM).
Yanagisawa K; Omori Y; Fukushima S; Iwasaki N; Hashimoto N; Iwamoto Y
Endocr J; 2010; 57(2):181-3. PubMed ID: 19952461
[TBL] [Abstract][Full Text] [Related]
17. A case of idiopathic type 1 diabetes with subsequent recovery of endogenous insulin secretion despite initial diagnosis of fulminant type 1 diabetes.
Kaneko K; Satake C; Yamamoto J; Takahashi H; Sawada S; Imai J; Yamada T; Katagiri H
Endocr J; 2017 Mar; 64(3):369-374. PubMed ID: 28070056
[TBL] [Abstract][Full Text] [Related]
18. Autoantibody recognition of COOH-terminal epitopes of GAD65 marks the risk for insulin requirement in adult-onset diabetes mellitus.
Falorni A; Gambelunghe G; Forini F; Kassi G; Cosentino A; Candeloro P; Bolli GB; Brunetti P; Calcinaro F
J Clin Endocrinol Metab; 2000 Jan; 85(1):309-16. PubMed ID: 10634404
[TBL] [Abstract][Full Text] [Related]
19. Impaired insulin secretion in non-diabetic offspring of probands with latent autoimmune diabetes mellitus in adults.
Vauhkonen I; Niskanen L; Knip M; Ilonen J; Vanninen E; Kainulainen S; Uusitupa M; Laakso M
Diabetologia; 2000 Jan; 43(1):69-78. PubMed ID: 10663218
[TBL] [Abstract][Full Text] [Related]
20. [Diabetes mellitus, but which type?].
Hoekstra JB; de Koning EJ
Ned Tijdschr Geneeskd; 2004 Apr; 148(16):761-4. PubMed ID: 15129562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
